Lymphatic mapping and sentinel lymph node biopsy for nonmelanoma skin cancers.
The use of lymphatic mapping and sentinel lymph node biopsy has profoundly changed the management of patients with malignant melanoma. This technique may also be useful to identify patients with micrometastases of other skin cancers in the regional lymph nodes. This article, reviews the rationale and initial experience of lymphatic mapping for nonmelanoma skin cancers. The technical considerations of the lymphatic mapping for these skin cancer patients are also discussed.
Pu
L L
LL
Division of Plastic Surgery, University of South Florida College of Medicine, Tampa, USA.
Cruse
C W
CW
D001706:Biopsy; D004396:Coloring Agents; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis / Q000473:pathology*; D008297:Male; D009367:Neoplasm Staging; D019275:Radiopharmaceuticals; D012307:Risk Factors; D012878:Skin Neoplasms / Q000473:pathology*; D013671:Technetium Tc 99m Sulfur Colloid
D004396:Coloring Agents; D019275:Radiopharmaceuticals; D013671:Technetium Tc 99m Sulfur Colloid